DX Group
DX
$12.76
+0.39%
Dynex Capital, Inc. is a real estate investment trust (REIT) that invests primarily in agency residential and commercial mortgage-backed securities (MBS) guaranteed by U.S. government-sponsored enterprises. As an internally managed mortgage REIT, it distinguishes itself through a focus on delivering sustainable dividends via leveraged MBS investments, operating in a niche within the broader real estate finance sector. The current investor narrative centers on the impact of interest rate volatility on its net interest spread and book value, with recent quarterly results showing a net loss due to elevated interest expenses, while the stock trades near its 52-week low amid a challenging rate environment.…
DX
DX Group
$12.76
Investment Opinion: Should I buy DX Today?
Rating: Hold. The thesis is that DX offers a high dividend yield and potential for price appreciation if interest rates decline, but current financial losses and high leverage make it too risky for a Buy. The analyst consensus is Buy with a $14.75 average target, but the stock's recent performance and fundamental weakness warrant caution.
Supporting Evidence: Revenue grew 170.8% YoY to $257.39 million, but net income was -$80.36 million. The forward P/E of 7.99x is low, but only if earnings materialize. The price-to-book ratio of 0.71x suggests the stock is cheap relative to book value, but book value may be overstated if MBS values decline. Free cash flow was positive at $69.85 million in Q1 2026, but the company relies heavily on external financing. The dividend yield of 14.18% is attractive but may not be sustainable if losses continue.
Risks & Conditions: The biggest risks are (1) further interest rate increases compressing net interest margins, (2) a dividend cut if earnings do not recover, and (3) dilution from additional equity issuance. This Hold would upgrade to Buy if the company reports two consecutive quarters of positive net income and the stock holds above $12.00. It would downgrade to Sell if the dividend is cut or if the stock breaks below $11.83. Overall, DX appears fairly valued given the risks, but the high yield provides a floor for patient investors.
Sign up to view all
DX 12-Month Price Forecast
The outlook for DX is highly dependent on interest rate movements. The base case (50% probability) assumes stabilization and gradual recovery, with the stock trading in a $13-$14.50 range. The bull case (25%) requires rate cuts and a return to profitability, pushing the stock to $15. The bear case (25%) involves further losses and a dividend cut, driving the stock below $12. The neutral stance reflects the balanced risks: the high yield provides support, but the negative earnings and leverage create significant downside. An upgrade to bullish would require two consecutive quarters of positive net income; a downgrade to bearish would follow a dividend cut or a break below $11.83.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on DX Group's 12-month outlook, with a consensus price target around $14.75 and implied upside of +15.6% versus the current price.
Average Target
$14.75
0 analysts
Implied Upside
+15.6%
vs. current price
Analyst Count
—
covering this stock
Price Range
$15 - $15
Analyst target range
Five analysts cover Dynex Capital, with a consensus recommendation of 'Buy' (mean recommendation 1.83 on a 1-5 scale). The average target price is $14.75, implying 17.1% upside from the current price of $12.60. The distribution leans bullish, with no sell ratings and a mix of Buy and Neutral ratings. The target range spans from $14.50 (low) to $15.00 (high), a narrow spread of $0.50, indicating relatively high conviction among analysts. The high target of $15.00 assumes a return to normalized earnings and book value stability, while the low target of $14.50 still implies upside. Recent ratings actions show no changes in the past three months, with UBS maintaining Neutral and Jones Trading and KBW reiterating Buy/Outperform, suggesting stable sentiment. The tight target range and bullish consensus support a positive outlook, but the stock's recent price decline below $13 may test analyst conviction.
Bulls vs Bears: DX Investment Factors
Dynex Capital presents a high-risk, high-reward opportunity. The bull case rests on strong revenue growth, a cheap forward valuation (P/E 7.99x, P/B 0.71x), and analyst consensus with 17.1% upside. However, the bear case is equally compelling: the company posted a net loss of -$80.36 million in Q1 2026, has a debt-to-equity ratio of 5.65x, and the stock is in a sustained downtrend near its 52-week low. The single most important tension is whether the company can return to profitability as interest expenses stabilize or decline. If the Fed cuts rates, DX could see a sharp recovery; if rates remain high, further losses and dividend cuts are possible. Currently, the bearish evidence (negative earnings, high leverage, price weakness) outweighs the bullish case, making this a speculative hold.
Bullish
- Strong Revenue Growth: Revenue surged 170.8% year-over-year to $257.39 million in Q1 2026, driven by a larger MBS portfolio. This rapid top-line expansion demonstrates the company's ability to scale its asset base aggressively.
- Attractive Forward Valuation: With a forward P/E of 7.99x based on estimated EPS of $1.61, the stock appears cheap relative to expected earnings recovery. The price-to-book ratio of 0.71x also suggests the stock trades below its net asset value.
- Analyst Consensus Buy: Five analysts rate the stock a Buy with a mean target of $14.75, implying 17.1% upside from the current price of $12.60. The tight target range ($14.50-$15.00) reflects high conviction in a recovery.
- High Dividend Yield: The dividend yield stands at 14.18%, supported by a payout ratio of 77.3% of trailing earnings. For income-focused investors, this yield is exceptionally attractive, though sustainability depends on earnings recovery.
Bearish
- Net Loss and Negative Margin: Q1 2026 net income was -$80.36 million, swinging from a profit of $185.36 million in Q4 2025. The net margin of -31.2% highlights severe profitability pressure from rising interest expenses of $178.14 million.
- Extreme Leverage Risk: Debt-to-equity ratio of 5.65x is very high, amplifying both returns and risks. The current ratio of 0.06 indicates potential liquidity stress, as short-term assets are insufficient to cover liabilities.
- Persistent Price Downtrend: The stock is down 13.82% over six months and 10.51% year-to-date, significantly underperforming the S&P 500. It trades near its 52-week low of $11.83, with negative relative strength of -21.03% over six months.
- Interest Rate Sensitivity: As a mortgage REIT, DX is highly sensitive to interest rate changes. The Q1 net loss was driven by a 33.4% increase in interest expenses year-over-year, and further rate hikes could compress net interest spreads.
DX Technical Analysis
The stock is in a sustained downtrend, with a 1-year price change of -0.55% and a 6-month change of -13.82%, significantly underperforming the S&P 500's 1-year gain of 16.47%. Currently trading at $12.60, it sits at 84.4% of its 52-week range ($11.83-$14.93), near the lower end, suggesting bearish sentiment and potential value opportunity but also risk of further decline. The 1-month price change of -3.15% and 3-month change of -8.43% indicate accelerating short-term weakness, diverging from the flatter 1-year trend, which could signal a deepening downtrend rather than a mean-reversion setup. Relative strength metrics are deeply negative, with 1-month relative strength of -3.93% versus the S&P 500, confirming persistent selling pressure. The 52-week low of $11.83 provides key support; a break below would open the door to further downside, while resistance sits at the 52-week high of $14.93. Beta of 0.93 indicates slightly lower volatility than the market, but the stock's high debt-to-equity ratio of 5.65 amplifies financial risk, making it sensitive to interest rate moves.
Beta
0.94
0.94x market volatility
Max Drawdown
-17.4%
Largest decline past year
52-Week Range
$12-$15
Price range past year
Annual Return
+1.5%
Cumulative gain past year
| Period | DX Return | S&P 500 |
|---|---|---|
| 1m | -1.9% | +3.6% |
| 3m | -4.4% | +5.1% |
| 6m | -8.9% | +13.8% |
| 1y | +1.5% | +22.2% |
| ytd | -9.4% | +13.1% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
DX Fundamental Analysis
Revenue has grown strongly, with Q1 2026 revenue of $257.39 million representing a 170.8% year-over-year increase, driven by a larger MBS portfolio. However, this growth is fueled by aggressive leverage, as total debt-to-equity stands at 5.65, and net income was -$80.36 million in Q1 2026, swinging from a profit of $185.36 million in Q4 2025. The company is unprofitable on a trailing basis, with a net margin of -31.2% in Q1 2026, though gross margin remains at 100% due to the nature of its interest income. Operating margin was 92.0% in Q1 2026, but high interest expenses of $178.14 million overwhelmed operating income, leading to the net loss. Free cash flow was positive at $69.85 million in Q1 2026, but the company relies heavily on external financing, as evidenced by $441.74 million in common stock issued and $7.48 billion in net cash from financing activities during the quarter. The debt-to-equity ratio of 5.65 and ROE of 12.96% (trailing) indicate high leverage amplifies returns but also risk, while the current ratio of 0.06 suggests liquidity stress.
Quarterly Revenue
$257390000.0B
2026-03
Revenue YoY Growth
+170.8%
YoY Comparison
Gross Margin
100.0%
Latest Quarter
Free Cash Flow
$184307000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Open an Account, get $2 TSLA now!
Valuation Analysis: Is DX Overvalued?
Since net income is negative on a trailing basis (TTM net income of -$80.36 million), the price-to-sales (PS) ratio is the primary valuation metric. The trailing PS ratio is 3.26, while the forward PE ratio (based on estimated EPS of $1.61) is 7.99, implying the market expects a return to profitability. The gap between negative trailing earnings and a positive forward PE suggests the market is pricing in a significant earnings recovery. Compared to the industry average (not provided), the PS ratio of 3.26x is difficult to assess without sector data, but for mortgage REITs, PS ratios are typically low due to high revenue leverage; a PS above 3x may indicate premium valuation relative to peers. Historically, the stock's PS ratio has ranged from 2.5x to 38.7x over the past five years, with the current 3.26x near the lower end of that range, suggesting it is cheap relative to its own history. The price-to-book ratio of 0.71 also indicates the stock trades below book value, which could signal undervaluation or reflect concerns about asset quality.
PE
5.6x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 1x~13x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
19.9x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: The primary financial risk is the company's extreme leverage, with a debt-to-equity ratio of 5.65x. This amplifies the impact of interest rate changes on net income. In Q1 2026, interest expenses of $178.14 million consumed 69.2% of revenue, leading to a net loss of -$80.36 million. The current ratio of 0.06 indicates that the company has virtually no liquidity buffer, relying on continuous access to repurchase agreement financing. Any disruption in the repo market could force asset sales at unfavorable prices. Additionally, the company issued $441.74 million in common stock in Q1 2026, diluting existing shareholders by 28% (shares outstanding rose from 156 million to 200 million).
Market & Competitive Risks: The stock's beta of 0.93 suggests slightly lower volatility than the market, but its high leverage makes it acutely sensitive to interest rate expectations. The 6-month relative strength of -21.03% versus the S&P 500 indicates persistent selling pressure. As a mortgage REIT, DX competes with other yield-oriented investments; if the 10-year Treasury yield remains elevated, investors may demand higher yields, pressuring the stock price. The narrow analyst target range ($14.50-$15.00) suggests limited upside even in a best-case scenario, and any negative surprise could trigger a sharp sell-off.
Worst-Case Scenario: If interest rates rise further or the Fed maintains a hawkish stance, DX could continue to report net losses, potentially forcing a dividend cut. The stock could break below its 52-week low of $11.83, with the next support level around $10.00 (a 20.6% decline from current levels). In a severe recession with credit market stress, the stock could fall to $9.00, representing a 28.6% loss from the current price of $12.60. The historical max drawdown of -17.44% provides a reference, but given the current leverage and earnings trajectory, a drawdown of 25-30% is plausible.
FAQ
The key risks are: (1) Interest rate risk: DX's net income is highly sensitive to interest rates; a 1% rise in rates could increase interest expenses by ~$20 million per quarter, worsening losses. (2) Leverage risk: Debt-to-equity of 5.65x amplifies losses and could force asset sales if financing dries up. (3) Dividend risk: The 14.18% yield may be cut if losses persist; the payout ratio is 77.3% of trailing earnings, but earnings are negative. (4) Dilution risk: The company issued $441.74 million in stock in Q1 2026, diluting shareholders by 28%. The most severe risk is a dividend cut, which could trigger a sell-off to the 52-week low of $11.83 or lower.
The 12-month forecast is mixed. The base case (50% probability) sees the stock trading between $13.00 and $14.50, assuming stable interest rates and a gradual return to profitability. The bull case (25% probability) targets $14.50-$15.00, driven by Fed rate cuts and positive earnings. The bear case (25% probability) sees the stock falling to $10.00-$11.83 if rates rise or the dividend is cut. Analyst targets average $14.75, implying 17.1% upside. The most likely scenario is the base case, with the stock recovering modestly as the company works through its interest expense challenges. However, the forecast is highly uncertain and depends on macroeconomic factors.
DX appears undervalued on a forward basis but fairly valued given current losses. The forward P/E of 7.99x is low, and the price-to-book ratio of 0.71x indicates the stock trades below book value. However, trailing earnings are negative, so traditional P/E is not applicable. The price-to-sales ratio of 3.26x is near the low end of its 5-year range (2.5x-38.7x), suggesting it is cheap relative to history. Compared to the mortgage REIT sector, a P/B below 1.0x is common for companies with stressed book values. The market is pricing in an earnings recovery; if that fails to materialize, the stock could be overvalued. Overall, DX is undervalued if you believe in the earnings recovery, but fairly valued if you discount the risks.
DX is a high-risk, high-yield investment. The stock offers a 14.18% dividend yield and trades at a forward P/E of 7.99x, with analysts seeing 17.1% upside to a $14.75 average target. However, the company posted a net loss of -$80.36 million in Q1 2026, has a debt-to-equity ratio of 5.65x, and the stock is in a downtrend near its 52-week low. It could be a good buy for aggressive income investors who believe interest rates will decline and the company will return to profitability. For conservative investors, the risks of dividend cuts and further price declines outweigh the potential rewards. A Hold rating is appropriate until earnings improve.
DX is better suited for short-to-medium-term trading rather than long-term holding. The stock's beta of 0.93 indicates market-like volatility, but its high leverage and sensitivity to interest rates make it a tactical play. The dividend yield is attractive for income, but the sustainability is questionable given negative earnings. Long-term investors face dilution risk and potential book value erosion. A minimum holding period of 6-12 months is recommended to allow for an interest rate catalyst. For short-term traders, the stock's proximity to its 52-week low offers a potential mean-reversion trade, but the downtrend suggests caution. DX is not a 'buy and forget' stock; it requires active monitoring of interest rates and earnings.